Rapid Therapeutic Science Laboratories, Inc. (RTSL)

OTCMKTS: RTSL · Delayed Price · USD

0.0050

0.00 (0.00%)

Apr 10, 2024, 11:09 AM EDT - Market closed

RTSL Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2019	2017	2016	2015	2014	2013
Revenue	0	0	0.01	0	0	0	0	0
Revenue Growth (YoY)	-	-94.16%	-	-	-	-	-	-
Cost of Revenue	0	0	0.01	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0
Selling, General & Admin	1.24	2.11	0.17	0.14	0.02	0.01	0.01	0.02
Other Operating Expenses	0.02	0.06	0	0.02	0	0	0	0
Operating Expenses	1.26	2.17	0.17	0.15	0.02	0.01	0.01	0.02
Operating Income	-1.26	-2.17	-0.17	-2.52	-0.02	-0.01	-0.01	-0.02
Interest Expense	1.9	1.33	0.18	0.03	0	0	0	0
Other Expense / Income	-1.36	-0.63	-	-0.03	-	-	-	-
Pretax Income	-1.79	-2.87	-0.35	-2.55	-0.02	-0.01	-0.01	-0.02
Income Tax	-0.1	1.33	-0	0.03	0	0	0	0
Net Income	-1.69	-4.2	-0.35	-2.55	-0.02	-0.01	-0.01	-0.02
Shares Outstanding (Basic)	8	8	0	0	0	0	0	0
Shares Outstanding (Diluted)	8	8	0	0	0	0	0	0
Shares Change	1.54%	15742.13%	-51.18%	-9.00%	-	-	-	-
EPS (Basic)	-0.22	-0.55	-7.24	-25.88	-0.20	-0.11	-0.11	-0.17
EPS (Diluted)	-0.22	-0.55	-7.24	-25.88	-0.20	-0.11	-0.11	-0.17
Free Cash Flow	-1.19	-2.5	-0.26	-0.17	-0.02	-0.01	-0.01	-0.01
Free Cash Flow Per Share	-0.15	-0.33	-5.43	-1.71	-0.20	-0.10	-0.08	-0.12
Gross Margin	-	62.55%	21.71%	-	-	-	-	-
Operating Margin	-	-406422.28%	-1856.77%	-	-	-	-	-
Profit Margin	-	-786015.73%	-3817.06%	-	-	-	-	-
Free Cash Flow Margin	-	-468476.03%	-2863.97%	-	-	-	-	-
EBITDA	-1.24	-2.11	-0.17	-0.14	-0.02	-0.01	-0.01	-0.02
EBITDA Margin	-	-395961.80%	-1856.77%	-	-	-	-	-
Depreciation & Amortization	0.02	0.06	0.04	0.02	0	0	0	0
EBIT	-1.26	-2.17	-0.21	-0.15	-	-	-	-
EBIT Margin	-	-406422.28%	-2267.10%	-	-	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.